Bespoke Members
Introduction
This workshop will provide a scientific backed overview for clinical practice on the commonality, importance, and clinical impact of substance misuse for anxiety/depression
The event will be equivalent to 2.3/4hrs of CPD.
Content
This workshop will provide a scientific backed overview for clinical practice on (1) the prevalence of substance misuse in outpatient settings, (2) discuss the role of substance use in the onset, maintenance, and relapse of anxiety/depression, (3) discuss the role of anxiety/depression in the onset, maintenance, and relapse of substance misuse, (4) offer an integrated theoretical perspective on substance misuse comorbidity with anxiety/depression, and (5) discuss integrated assessment and treatment options for this comorbid population.
Learning Objectives
(1) To understand the prevalence of substance misuse among anxiety/depressive disorders
(2) To understand how to conceptualize the interplay between substance misuse and anxiety and depression
(3) To understand integrated treatment options for anxiety/depressive patients who are engaged in substance misuse
Training Modalities
I will present via a PowerPoint presentation. After each section of the content presentation (1-5 above), I will field questions and offer clinical examples.
Key References
Anker J. J., Kushner, M.G. (2019). Co-Occurring Alcohol Use Disorder and Anxiety: Bridging
Psychiatric, Psychological, and Neurobiological Perspectives. Alcohol Res. 30;40(1):arcr.v40.1.03. doi: 10.35946/arcr.v40.1.03. PMID: 31886106; PMCID: PMC6927748.
Buckner, J. D., Morris, P. E., & Zvolensky, M. J. (2021). Integrated cognitive
behavioral therapy for comorbid cannabis use and anxiety disorders: The impact of severity of cannabis use. Experimental and Clinical Psychopharmacology. https://psycnet.apa.org/doi/10.1037/pha0000456
Rogers, A. H., Zvolensky, M. J., Ditre, J. W., Buckner, J. D., & Asmundson, G. J. G. (2021). Association of opioid misuse with anxiety and depression: A systematic review of the literature. Clinical Psychology Review, 84, 101978. https://doi.org/10.1016/j.cpr.2021.101978
Zvolensky, M. J., Shepherd, J. M., Redmond, B. Y., Jo, D., Garey, L., & Thai, J. (in press).
Anxiety sensitivity and substance use behavior and disorders. Current Addiction Reports.
Leventhal, A. M., & Zvolensky, M. J. (2015). Anxiety, depression, and cigarette smoking: A transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity. Psychological Bulletin, 141, 176-212. https://psycnet.apa.org/doi/10.1037/bul0000003
About the presenter
Dr. Zvolensky is a Distinguished Professor in the Department of Psychology at the University of Houston and Director of the Research on Emotion, Substance Use Treatment Outcomes, Rehabilitation, and Empowerment (RESTORE) Laboratory and Substance Use Treatment Clinic. He has published over 1000 peer-reviewed articles and books/book chapters on the co-occurrence of anxiety and stress-related psychopathology with substance use disorders, health behaviour problems (e.g., sedentary behaviour), and physical illness (e.g., HIV/AIDs, chronic pain). His work has been continuously funded by NIH since his doctoral degree (2001). Clinically, he has directed an outpatient treatment clinic since 2011 that has served well over 3,000 patients with substance use disorders and comorbid mental and physical health disorders via cognitive-behavioural and third wave behaviour therapy integrated treatments. He has worked with diverse groups, including many that are established health disparity populations. Much of his current work is focused on increasing accessibility and use of integrated treatments for substance use disorders and comorbid anxiety and depression via digital platforms.
Who should attend
Primary care low and high intensity practitioners, psychologists, nurse therapists, counsellors, and psychiatrists, occupational therapists, and social workers.